A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response
Clinical trial NCT04176939 · COMPLETED
Trial details
- NCT number
- NCT04176939
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2022-08-12
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.